Effect of tofacitinib on cardiovascular events and all-cause mortality in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: We aimed to systematically assess a possible association of tofacitinib therapy with cardiovascular events (CVEs) and all-cause mortality. METHODS: Systematic searches of PubMed, Embase, and Cochrane Library were conducted from inception through March 2019. Randomized controlled trials i...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Wenhui, Xiao, Shiyu, Huang, Yanrong, Sun, Xiaoying, Zhang, Zhuoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918042/
https://www.ncbi.nlm.nih.gov/pubmed/31897092
http://dx.doi.org/10.1177/1759720X19895492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918042/
https://www.ncbi.nlm.nih.gov/pubmed/31897092
http://dx.doi.org/10.1177/1759720X19895492

Ejemplares similares